Centers for Disease Control guidelines for prevention and control of Chlamydia trachomatis infections. Summary and Commentary.
Recent guidelines issued by the Centers for Disease Control discuss prevention and control of Chlamydia trachomatis infection. Chlamydia trachomatis is the commonest sexually transmitted infection in the United States. The rate of infection has increased in the past 10 years. The guidelines do not discuss control of trachoma and only briefly discuss lymphogranuloma venereum. Education of health care professionals and the public about C. trachomatis is recommended, along with the establishment of a nationwide surveillance system.
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002487:Centers for Disease Control and Prevention, U.S.; D002690:Chlamydia Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D002692:Chlamydia trachomatis; D004318:Doxycycline / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy / Q000382:microbiology; D011247:Pregnancy; D012749:Sexually Transmitted Diseases / Q000517:prevention & control; D013752:Tetracycline / Q000627:therapeutic use; D014481:United States
D000900:Anti-Bacterial Agents; D013752:Tetracycline; D004318:Doxycycline